1-3 of 3
Yuanzhen Cao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction

Fang Liu, MD PhD, Hongyu Zhang, MD PhD, Xiao Wang, MD PhD, Yisong Xiong, PhD, Yuanzhen Cao, Yi Su, MD, Hai Yi, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 38.
https://doi.org/10.1182/blood-2019-122964
Published: 2019
Journal Articles

First-in-Human CD4 CAR Clinical Trial on Peripheral T-Cell Lymphoma

Hongyu Zhang, MD PhD, Jia Feng, MD PhD, Wenli Zhang, MD, Qi Chen, PhD, Yuanzhen Cao, Kevin Pinz, Fang Liu, MD PhD, Yu Ma, Masayuki Wada, PhD, Yupo Ma, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2881.
https://doi.org/10.1182/blood-2019-122789
Published: 2019
Journal Articles

First-in-Human CLL1-CD33 Compound CAR T Cell Therapy Induces Complete Remission in Patients with Refractory Acute Myeloid Leukemia: Update on Phase 1 Clinical Trial

Fang Liu, MD PhD, Yuanzhen Cao, Kevin Pinz, Yu Ma, Masayuki Wada, PhD, Kevin Chen, Gina Ma, Jiaqi Shen, Charlotte Olivia Tse, Yi Su, MD, Yisong Xiong, PhD, Guangcui He, MD, Yecheng Li, MD, Yupo Ma, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 901.
https://doi.org/10.1182/blood-2018-99-110579
Published: 2018